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My colleagues and I are pleased to submit our manuscript entitled “Effect of polar 
amino acid incorporation on Fmoc-diphenylalanine-based tetrapeptides” 
for publication in Chemical Communications.
Here, we show that the incorporation of polar amino acids bearing positive, 
negative or no charge into the widely used Fmoc-diphenylalanine short peptide motif 
has significant effects on peptide self-assembly and function. Through comprehensive 
characterisation we show that these polar tetrapeptide hydrogels display differences in 
hydrogel stiffness (across three orders of magnitude) and nanoscale morphology. We 
validate that the incorporation of polar, charged amino acids imparts an electrostatic 
charge onto the tetrapeptide which is conserved throughout the solution and gel state. 
This charge greatly affects the biocompatibility of these tetrapeptides in both the 
solution and gel state, with cytotoxic tetrapeptides in the solution state being well 
tolerated in the gel state, and vice versa. Finally, we gain insights these biocompatibility 
trends through tethered bilayer lipid membrane (tBLM) experiments, which confirm 
interactions of positively charged tetrapeptides with cell-mimetic membranes.
To the best of our knowledge, our report is the first to show that differences in 
biocompatibility depend not only the electrostatic charge of the peptides, but also the 
manner in which peptide biocompatibility is evaluated. Many papers, when assessing 
the biocompatibility of self-assembling peptides, use a solution cytotoxicity assay (i.e. 
treating a monolayer of cells with peptides at well below their critical gel 
concentration). In this work, we show that peptides which demonstrate excellent 
biocompatibility as determined through this method are unable to support cells in the 
gel state, owing to a lack of attachment. We further show that there is no relationship 
between hydrogel stiffness and biocompatibility for these tetrapeptide hydrogels.
Our work illustrates the importance of electrostatic charge on peptide self-
assembly and biocompatibility, and that the method used to evaluate biocompatibility 
is reflective of the intended applications of these materials. This work has applications 
in tissue engineering, supramolecular chemistry and biochemistry. Thus, we believe 
that our work is well-suited for the broad readership of Chemical Communications, 
and will attract readers from across supramolecular chemistry, biomaterials, and 
tissue engineering communities to the journal.
We are looking forward to your and the reviewer’s comments and please do not 
hesitate to contact us if you require further information.
Sincerely,
Dr Adam Martin
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Effect of polar amino acid incorporation on Fmoc-
diphenylalanine-based tetrapeptides 
A. Daryl Ariawan,a Biyun Sun,a Jonathan P. Wojciechowski,b Ian Lin,c Eric Y. Du,c Sophia C. 
Goodchild,d Charles G. Cranfield,e Lars M. Ittner,a Pall Thordarson,c Adam D. Martin*a 
Peptide hydrogels show great promise as extracellular matrix 
mimics due to their tuneable, fibrous nature. Through 
incorporation of polar, charged amino acids into the Fmoc-
diphenylalanine motif, we show that electrostatic charge 
plays a key role in the self-assembly and biocompatibility of 
these peptides in both the sol and gel state.  
Since the diphenylalanine sequence was first reported to self-
assemble into nanotubes,1 it has been the basis for a wealth of 
research, ranging from electronically responsive materials,2,3 
to sensors,4,5 to cell scaffolds.6,7 The addition of the amine-
protecting Fmoc moiety to the N-terminus of diphenylalanine 
results in the self-assembly of nanofibres under aqueous 
conditions, yielding self-supporting hydrogels.8 These 
hydrogels or derivatives thereof have since provided a number 
of elegant examples of self-assembly; to support different cell 
types,9-11 deliver therapeutic cargo12,13 or even selectively 
destroy cancerous cells.14 As the Fmoc-diphenylalanine (Fmoc-
FF) sequence itself does not promote cell adhesion, the 
integrin binding motif arginine-glycine-aspartic acid (RGD) has 
been either attached to, or co-assembled with Fmoc-FF to 
improve cell viability.15,16 It has been shown that even co-
assembling Fmoc-3F-Phe-Arg-OH and Fmoc-3F-Phe-Asp-OH 
has a synergistic effect on fibroblast growth.17 
 In addition to the RGD sequence, other epitopes, typically 
laminin and collagen-based, have promoted cell adhesion in 
peptide hydrogels.18-21 Recent work has shown that the 
spacing between adjacent cell adhesive epitopes is important 
for the adhesion of endothelial cells.22 Although control over 
epitope incorporation and spacing throughout a scaffold is 
useful for enhancing adhesion, in many cases the surface 
presentation of the desired peptide sequence is unknown. 
 One strategy which has been widely applied in the polymer 
hydrogel field is to replace cell adhesive epitopes with 
electrostatic charge.23-25 A positively charged scaffold interacts 
favourably with the negatively charged cell membrane, 
resulting in enhanced adhesion. This has been applied to 
peptide hydrogels through the co-assembly of non-gelators 
Fmoc-lysine (Fmoc-K) or poly-lysine with Fmoc-FF scaffolds.26,27 
Surprisingly, relatively little work has been undertaken on the 
incorporation of charged residues into self-assembling peptide 
sequences, with the exception of the pioneering work on 
octapeptides bearing complementary charges.28,29 The 
incorporation of positively charged lysine or ornithine at the C-
terminus of Fmoc-FF has been reported, however the ability of 
these peptides to support cell growth was not established.30 
 Herein we have inserted the polar anionic amino acids 
aspartic acid (D) and glutamic acid (E), polar neutral amino 
acids asparagine (N) and glutamine (Q), and polar cationic 
amino acids arginine (R) and lysine (K) at the N-terminus of the 
diphenylalanine self-assembling sequence. All six tetrapeptides 
give self-supporting hydrogels. Zeta potential measurements 
show that the electrostatic charge imparted by the 
incorporation of polar amino acids is maintained in the gel 
state, and the biocompatibility of these charged tetrapeptides 
is evaluated in both the solution and gel state.  
 The Fmoc-diphenylalanine sequence was used as a starting 
point for the design of the peptides examined in this study, as 
its self-assembly has been well established.8 We inserted polar 
amino acids at the N-terminus of the peptide, ensuring that 
the diphenylalanine sequence was conserved (Fig. 1). Charged 
amino acids were inserted at the N-terminus of the peptide to 
minimise chances of the peptide C-terminus forming dimers 
with acidic residues (D, E), or salt bridges with cationic 
residues (R, K). Tripeptides containing a single polar amino acid 
were also synthesised, however cationic tripeptides Fmoc-RFF 
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and Fmoc-KFF were insoluble in aqueous media, possibly due 
to their zwitterionic nature.  
 
Fig. 1 – The Fmoc tetrapeptides which were synthesised for this study, featuring 
insertion of (top) polar anionic, (middle) polar neutral and (bottom) polar 
cationic amino acids inserted at the N-terminal end of the diphenylalanine 
sequence. 
 All tetrapeptides self-assembled into hydrogels. For anionic 
Fmoc-DDFF and Fmoc-EEFF, gelation was accomplished using a 
pH switch employing glucono-δ-lactone (GdL),31 with these 
peptides having minimum gel concentrations (mgc) of 0.05% 
and 0.25% (w/v), respectively (Fig. S2a, b). For polar neutral 
tetrapeptides Fmoc-NNFF and Fmoc-QQFF the GdL pH switch 
mechanism yielded hydrogels with mgc values of 0.25% and 
0.10% (w/v), respectively (Fig. S2c, d). Polar cationic 
tetrapeptides Fmoc-RRFF and Fmoc-KKFF were water soluble, 
and addition of acid served only to enhance their solubility. 
Heterogeneous hydrogels were obtained through the addition 
of dilute base (NaOH), however, the addition of an ionic 
solution (i.e. cell culture media) gave homogenous hydrogels 
with an mgc of 0.5% (w/v) for both Fmoc-RRFF and Fmoc-KKFF 
(Fig. S2e, f). 
 Atomic force microscopy (AFM) imaging of hydrogels 
shows the presence of nanofibres for anionic (Fmoc-DDFF, 
Fmoc-EEFF), and cationic (Fmoc-RRFF, Fmoc-KKFF) 
tetrapeptides, however, for neutral tetrapeptides Fmoc-NNFF 
and Fmoc-QQFF, globular aggregates are observed, potentially 
suggesting a different self-assembly mechanism (Fig. 2). 
Distinct right-handed fibres of Fmoc-EEFF can be observed (Fig. 
2b, pitch approximately 35 nm). Fibre diameters ranged from 
2.8 ± 1.1 nm for Fmoc-KKFF to 6.5 ± 1.1 nm for Fmoc-EEFF 
(Table S1). No trends relating to fibre diameter and peptide 
charge were observed. 
 The secondary structure of the peptides was assessed 
through a combination of circular dichroism (CD) and 
attenuated total reflectance infrared spectroscopy (ATR-IR). 
The parent Fmoc-FF peptide is known to self-assemble into β-
sheets, yielding a strong absorbance at approximately 220 
nm.32 This is also the case for Fmoc-DDFF, with Fmoc-NNFF, 
Fmoc-QQFF and Fmoc-KKFF giving slightly shifted absorption 
maxima (215 nm) which indicate β-sheet formation (Fig. S3). 
Alternately, Fmoc-EEFF and Fmoc-RRFF show a shifted 
maximum at 230 nm. ATR-IR spectra confirm β-sheet 
formation for all peptides (Fig. S4), with every tetrapeptide 
displaying an absorption between 1630 – 1640 cm-1.33,34 
 
Fig. 2 – Atomic force microscopy images of each tetrapeptide, showing self-
assembly into fibres in the case of (a, b) polar anionic and (e, f) polar cationic 
tetrapeptides and (c, d) globular aggregates for polar neutral tetrapeptides. 
Samples were prepared through spread coating at 0.05% (w/v) onto freshly 
cleaved mica, scale bar represents 500 nm for a, e and f, and 300 nm for b, c and 
d. 
 We evaluated the mechanical properties of the hydrogels 
formed by each polar tetrapeptide (Fig. 3a, Fig S5-S10) through 
rheology at concentrations of 1, 0.5 and 0.25% (w/v), as these 
were the concentrations used for contact cytotoxicity. The 
rheology of Fmoc-RRFF and Fmoc-KKFF was not studied at 
0.25% (w/v), as this fell below their mgc. As expected, 
hydrogel stiffness increased with concentration for all 
tetrapeptide hydrogels. Anionic tetrapeptide Fmoc-DDFF gave 
the stiffest hydrogels, likely owing to formation of fibre 
bundles (Fig. 2a), as bundle size is proportional to hydrogel 
stiffness.35 The large difference in stiffness between Fmoc-
NNFF and Fmoc-QQFF is due to the propensity of Fmoc-QQFF 
to aggregate over time, with this metastability adversely 
affecting its mechanical properties. Polar cationic 
tetrapeptides Fmoc-RRFF and Fmoc-KKFF gave softer 
hydrogels, due to the use of a salt screen method to trigger 
gelation, this tends to “freeze in” the fibre structure,36 
compared to the slow hydrolysis of GdL which allows for 
evolution of hierarchical networks.  
 
Fig. 3 – Characterisation of polar tetrapeptide hydrogels. (a) Storage modulus of 
tetrapeptide hydrogels at concentrations relevant to cytotoxicity studies, showing 
storage moduli which span several orders of magnitude dependent on peptide 
sequence. (b) Zeta potential of polar tetrapeptides in both the sol and gel state, 
showing the expected positive and negative charges for each peptide, which is then 
reduced upon gelation. Error bars represent standard deviation from the mean. 
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 Next, the pKa of each peptide was determined (Fig S11). 
The pKa of Fmoc-FF is approximately 7,37 and that the addition 
of aspartic acid groups lowers pKa values.38 This is also 
observed for our peptides, with Fmoc-DDFF having a pKa of 4.8 
and Fmoc-EEFF a pKa of 6.2. This agrees with the lower pKa of 
aspartic acid relative to glutamic acid (3.65 versus 4.25, 
respectively). Fmoc-KKFF yielded a pKb of 11.1, and Fmoc-RRFF 
a pKb of 11.2, suggesting that in this case, the nature of the 
cationic amino acid does not affect the peptide pKb.  
 To show that the incorporation of polar, charged amino 
acids translates to the charged sols and hydrogels, zeta 
potentials were recorded for tetrapeptides in the sol and gel 
state (Fig. 3b). A negative zeta potential is observed for polar 
anionic and polar neutral tetrapeptides owing to the 
deprotonation of acidic residues required to solubilise the 
peptide. The polar cationic peptides Fmoc-RRFF and Fmoc-
KKFF, which were dissolved in water, have positive zeta 
potentials. For all tetrapeptides, the charge observed for the 
peptide sol was reduced upon gelation yet remained negative 
(for polar anionic/neutral tetrapeptides) or positive (for polar 
cationic tetrapeptides). To confirm that the zeta potential 
results were not an artefact of the equilibrium between 
monomeric and self-assembled peptides, the cationic dye 
Rhodamine 6G, was incubated with hydrogels of Fmoc-DDFF 
and Fmoc-KKFF (Fig. S12, S13), and its release monitored over 
24h. The amount of dye released is far greater for anionic 
Fmoc-DDFF than cationic Fmoc-KKFF, confirming that the 
tetrapeptides are indeed charged in the hydrogel state. 
 With the presence of electrostatic charge in both the sol 
and gel state established, the biocompatibility of these polar 
tetrapeptides in the sol and gel state was evaluated using the 
robust HEK-293T cell line. For solution cytotoxicity, 
tetrapeptides were prepared in cell culture media and added 
to a cell monolayer. In the solution state, all polar 
tetrapeptides except for Fmoc-RRFF are well tolerated up to 
0.1% (w/v). Above this concentration, aggregation effects start 
to occur for Fmoc-EEFF and Fmoc-QQFF, resulting in 
cytotoxicity.39 Fmoc-RRFF is cytotoxic at low concentrations (> 
0.01% (w/v)), due to its ability to interact with cell membranes. 
 Interestingly, the cytotoxicity of the polar tetrapeptides in 
the gel state shows an inverse correlation to that observed in 
the solution state, for anionic and cationic tetrapeptides. 
Fmoc-DDFF and Fmoc-EEFF show dramatically decreased cell 
viability, and Fmoc-RRFF and Fmoc-KKFF increased viability, 
with these trends especially evident at 1% (w/v). Polar neutral 
tetrapeptides Fmoc-NNFF and Fmoc-QQFF showed excellent 
viability across all concentrations. It should be noted that there 
is no apparent correlation between peptide mechanical 
properties (Fig. 3a) and biocompatibility (Fig. 4). 
 We hypothesise that negatively charged peptides, such as 
Fmoc-DDFF and Fmoc-EEFF have limited interactions with the 
negatively charged cell membrane. Whilst this gives good 
biocompatibility when treating adherent cells with peptide 
solutions (Fig. 4a), cells do not adhere to scaffolds composed 
of these peptides, decreasing cell viability (Fig. 4b). Alternately, 
positively charged Fmoc-KKFF and Fmoc-RRFF can interact with 
the cell membrane, potentially resulting in reduced viability in 
the solution state (as observed for Fmoc-RRFF), however in the 
gel state this attractive interaction between the cell 
membrane and hydrogel scaffold results in cell adherence and 
viability. Polar neutral tetrapeptides Fmoc-NNFF and Fmoc-
QQFF will not exhibit electrostatic-mediated interactions with 
the cell membrane, which translates to good cell viability in 
both the solution and gel state.  
 
Fig. 4 – Cytotoxicity of polar peptides towards HEK293T cells in (a) the solution state 
and (b) the gel state. Interestingly, many of the trends observed in the solution 
cytotoxicity assay are inverted in the gel state cytotoxicity measurements. (c-h) 
Tethered bilayer lipid membrane permeability measurements showing that polar 
cationic peptides (g) Fmoc-RRFF and (h) Fmoc-KKFF have the ability to interact with cell 
membranes. 
 To validate this hypothesis, we treated sparsely tethered 
lipid bilayer membranes (tBLMs) consisting of 1-Palmitoyl-2-
oleoylphosphatidylcholine (POPC) lipids with tetrapeptides and 
monitored electrical impedance over time. These cell-mimetic 
membranes have been used previously to assess the 
membrane disruptive activity of peptides.40-42 For polar anionic 
and polar neutral tetrapeptides, no interaction with the tBLMs 
were observed at all concentrations (Fig. 4c-f). Polar cationic 
peptides showed interactions with the tBLMs at 100 µM (Fig. 
4g, h), which is equivalent to approximately 0.02% (w/v). 
Fmoc-RRFF, in particular, shows a 50-fold increase in 
conductance relative to Fmoc-KKFF, suggesting a major 
disruption to the tBLM. Interestingly, this is exactly where the 
tetrapeptide begins to show cytotoxic effects in the solution 
state. The interactions of arginines with cell membranes are 
known and form the basis of many cell penetrating peptides 
including the TAT sequence, penetratin and oligoarginines.43   
 In conclusion, we have examined the effect of 
incorporating polar amino acids aspartic acid, glutamic acid, 
asparagine, glutamine, arginine and lysine into the Fmoc 
diphenylalanine self-assembling sequence, yielding cationic, 
neutral or anionic tetrapeptides. These polar amino acids 
affect both the mechanical properties and the nanoscale 
morphology of the resultant peptides. Zeta potential 
measurements in the sol and gel state show that anionic and 
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neutral peptides retain a negative charge due to the 
deprotonation of their acidic residues and C-terminus; whilst 
cationic tetrapeptides bear a positive charge. The biggest 
differences between these polar tetrapeptides is in their 
cytotoxicity, with anionic tetrapeptides Fmoc-DDFF and Fmoc-
EEFF being biocompatible when applied to cells in the solution 
state but cytotoxic in the gel state. The opposite trend is 
observed for cationic tetrapeptides Fmoc-RRFF and Fmoc-
KKFF, with Fmoc-RRFF being especially cytotoxic in the solution 
state, but both peptides being well-tolerated in their gel state. 
Polar neutral tetrapeptides Fmoc-NNFF and Fmoc-QQFF 
exhibited good biocompatibility in both the solution and gel 
state. This work highlights the important role that electrostatic 
interactions play when designing short peptide hydrogels for 
cell scaffolding applications, which will undoubtedly prove 
useful for the future rational design of these materials.  
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Solid phase peptide synthesis of capped dipeptides
Initial amino acid loading
2-chlorotrityl chloride resin (100-200 mesh; 1% DVB; 1.1 mmol/g) (500 mg, 0.55 mmol) was 
weighed into a 10 mL polypropylene syringe equipped with a porous polypropylene frit (Torviq 
SF-1000), which was used as the reaction vessel. The resin was washed with dichloromethane 
(3 × 5 mL) before being allowed to swell in dichloromethane (5 mL) for at least 0.5 h prior to 
the loading of the first amino acid. 
A solution of Fmoc-Phe-OH (3 equiv., 640 mg) was dissolved in a mixture of dry 
dichloromethane (2 mL), N,N-dimethylformamide (2 mL) and N,N-diisopropylethylamine 
(DIPEA) (8 equiv., 0.8 mL) and taken up into the syringe with resin and stirred overnight using 
an orbital shaker. The resin was then washed with dichloromethane (3 x 4mL) and N,N-
dimethylformamide (DMF) (3 × 4 mL).
N-terminal Fmoc deprotection
A solution of 20% (v/v) piperidine in DMF (2 × 4 mL) was added to the resin once for 1 min, 
then a fresh aliquot was taken up again and stirred for 10 mins. The solution was subsequently 
expelled and the resin washed with DMF (5 × 4 mL). The resulting resin-bound amine was 
used immediately in the next peptide coupling step. 
Amino acid coupling
The next amino acid  (3 equiv., masses as below) was dissolved in a 0.45 M DMF solution of 
1-hydroxybenzotriazole hydrate (HOBt·H2O)/N,N,N′,N′-tetramethyl-O-(1H-benzotriazol-1-
yl)uronium hexafluorophosphate (HBTU) (3 equiv.) and DIPEA (6 equiv., 0.6 mL) and this 
coupling solution added to the resin and stirred for 45 mins using an orbital shaker. The solution 
was expelled and the resin washed with DMF (5 x 4 mL).








After another N-terminal Fmoc deprotection, iterative couplings were performed in order to 
build up the required peptide sequence. 
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Cleavage of the peptide
After the final coupling step, the resin was washed with DMF (3 x 4 mL) and dichloromethane 
(3 x 4 mL). For all peptides except Fmoc-NNFF, Fmoc-QQFF and Fmoc-RRFF, a solution of 
1:9 dichloromethane: trifluoroacetic acid with three drops of water was then added to the resin, 
and the resin stirred for 2 hours using an orbital shaker. For Fmoc-NNFF and Fmoc-QQFF, the 
protected peptide was cleaved from the resin using 10% trifluoroacetic acid in dichloromethane 
and purified using semi-preparative HPLC, before lyophilisation and cleavage using 1:9 
dichloromethane: trifluoroacetic acid and three drops of water for 2 hours. For Fmoc-RRFF, a 
solution of trifluoroacetic acid, water and triisopropylsilane in a 95: 2.5: 2.5 ratio was added to 
the resin and the resin stirred for 3h. The cleavage solution was then expelled, the resin washed 
with dichloromethane (2 x 4 mL) and the solvents evaporated under a stream of nitrogen. The 
resulting residue was lyophilised and purified by semi-preparative HPLC using an 
acetonitrile/water gradient, giving a white fluffy solid.
Characterisation data for Fmoc-diaspartic acid-diphenylalanine (Fmoc-DDFF): IR: 3281 
(m), 3064 (w), 3032 (w), 1703 (s), 1645 (s), 1534 (s), 1498 (m), 1448 (w), 1408 (w), 1260 (m), 
1226 (s), 1192 (m), 1084 (w), 1049 (w), 916 (w), 739 (s), 699 (s); 1H NMR (400 MHz, DMSO-
d6)  12.06 (br s, 1H), 8.20 (d, J = 7.2 Hz, 1H), 7.89 (d, J = 6.9 Hz, 1H), 7.76-7.66 (m, 2H), 
7.41 (t, J = 7.0 Hz, 1H), 7.34-7.14 (m, 6H),  4.51 – 4.34 (m, 2H), 4.24 – 4.07 (m, 4H), 3.07-
2.87 (m, 2H), 2.79 – 2.73 (m, 0.5H), 2.65-2.57 (m, 1H), 2.47-2.39 (m, 0.5H). 13C NMR (101 
MHz, DMSO-d6)  173.08, 172.30, 172.25, 171.49, 171.05, 170.53, 156.31, 152.12, 151.75, 
148.32, 148.16, 144.29, 141.19, 137.98, 137.84, 129.68, 129.61, 128.68, 128.46, 128.11, 
127.57, 126.92, 125.81, 120.58, 54.18, 54.03, 50.07, 47.08, 37.79, 37.25, 36.37; HR-MS (ESI): 
calcd for C41H40N4O11 + Na+: 787.2634, found 787.2679.
Characterisation data for Fmoc-diglutamic acid-diphenylalanine (Fmoc-EEFF): IR: 3278 
(m), 3065 (w), 3032 (w), 1697 (s), 1665 (m), 1636 (s), 1537 (s), 1498 (m), 1447 (m), 1404 (w), 
1402 (w), 1286 (m), 1264 (s), 1219 (s), 1216 (s), 1104 (w), 1086 (w), 1041 (w), 914 (w), 785 
(w), 760 (m), 741 (s), 697 (s); 1H NMR (400 MHz, DMSO-d6) δ 8.31 (d, J = 7.7 Hz, 1H), 7.99 
(d, J = 8.2 Hz, 1H), 7.93–7.86 (m, 3H), 7.71 (t, J = 7.9 Hz, 2H), 7.56 (d, J = 8.0 Hz, 1H), 7.45–
7.38 (m, 2H), 7.36–7.30 (m, 2H), 7.29–7.12 (m, 10H), 4.58–4.42 (m, 2H), 4.32–4.18 (m, 4H), 
4.06–3.97 (m, 1H), 3.10–2.87 (m, 4H), 2.79–2.70 (m, 1H), 2.28–2.12 (m, 4H), 1.92–1.62 (m, 
4H). 13C NMR (126 MHz, DMSO-d6) δ 174.50, 174.44, 173.12, 171.77, 171.34, 171.14, 
156.43, 144.36, 144.18, 144.16, 137.95, 137.76, 129.58, 129.55, 128.66, 128.44, 128.12, 
127.57, 126.91, 126.69, 125.77, 125.75, 120.58, 66.16, 54.34, 53.93, 53.86, 52.11, 47.11, 
37.91, 37.16, 30.73, 30.46, 28.07, 27.68; HR-MS (ESI): calcd for C43H44N4O11 + Na+: 
793.3004, found 793.3087.
Characterisation data for Fmoc-diasparagine-diphenylalanine (Fmoc-NNFF): IR: 3284 (m), 
3067 (w), 1697 (m), 1643 (s), 1537 (s), 1442 (m), 1387 (w). 1321 (m), 1265 (s), 1200 (m), 910 
(w), 740 (s), 696 (s); 1H NMR (400 MHz, DMSO-d6) δ 8.14 (d, J = 7.5 Hz, 1H), 8.07 (d, J = 
7.5 Hz, 1H), 7.95 (d, J = 8.1 Hz, 1H), 7.82 (d, J = 7.8 Hz, 2H), 7.67–7.60 (m, 2H), 7.50 (d, J 
= 7.8 Hz, 1H), 7.38–7.30 (m, 3H), 7.28–7.25 (m, 2H), 7.25–7.22 (m, 1H), 7.21–7.18 (m, 2H), 
7.18–7.16 (m, 2H), 7.16–7.10 (m, 6H), 7.09–7.03 (m, 1H), 6.92 (s, 1H), 6.84 (s, 1H), 4.43–
4.24 (m, 4H), 4.23–4.10 (m, 3H), 3.04–2.82 (m, 3H), 2.76–2.65 (m, 1H), 2.50–2.46 (m, 1H), 
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2.40–2.24 (m, 3H). 13C NMR (126 MHz, DMSO-d6) δ 173.03, 172.11, 171.82, 171.19, 171.02, 
156.21, 144.31, 144.25, 144.22, 141.14, 138.35, 137.97, 129.61, 129.57, 129.50, 128.83, 
128.69, 128.51, 128.23, 128.11, 128.00, 127.60, 127.11, 126.89, 126.72, 126.62, 125.83, 
120.56, 66.35, 56.23, 54.43, 54.16, 52.05, 50.41, 47.04, 37.95, 37.36, 37.24; HR-MS (ESI): 
calcd for C41H42N6O9 + Na+: 763.3022, found 763.3097.
Characterisation data for Fmoc-diglutamine-diphenylalanine (Fmoc-QQFF): IR: 3303 (m), 
3066 (w), 1661 (s), 1637 (s), 1542 (s),  1444 (s), 1334 (w), 1270 (m), 1151 (m), 1010 (m), 755 
(s), 698 (s); 1H NMR (400 MHz, DMSO-d6) δ 8.33 (d, J = 8.2 Hz, 1H), 7.98 (d, J = 7.9 Hz, 
2H), 7.90 (d, J = 7.5 Hz, 2H), 7.72 (t, J = 7.5 Hz, 2H), 7.56 (d, J = 7.8 Hz, 1H), 7.42 (t, J = 
7.5 Hz, 2H), 7.37–7.28 (m, 4H), 7.28–7.24 (m, 4H), 7.23–7.19 (m, 6H), 7.15–7.11 (m, 1H), 
6.78 (d, J = 8.8 Hz, 2H), 4.57–4.40 (m, 2H), 4.29–4.18 (m, 4H), 4.01–3.93 (m, 1H), 3.11–2.88 
(m, 3H), 2.81–2.68 (m, 1H), 2.18–1.95 (m, 4H), 1.91–1.60 (m, 4H). 13C NMR (126 MHz, 
DMSO-d6) δ 174.40, 174.29, 173.12, 171.96, 171.43, 171.36, 156.45, 144.35, 144.25, 144.22, 
141.16, 137.96, 137.79, 129.57, 129.50, 128.82, 128.68, 128.47, 128.23, 128.12, 128.00, 
127.58, 127.11, 126.92, 126.72, 125.80, 120.57, 66.22, 56.23, 54.87, 53.93, 52.51, 47.09, 
37.95, 37.16, 32.06, 31.89, 28.70, 28.25; HR-MS (ESI): calcd for C43H46N6O9 + H+: 791.3345, 
found 791.3408.
Characterisation data for Fmoc-diarginine -diphenylalanine (Fmoc-RRFF): IR: 3288 (m), 
3189 (m), 3066 (m), 2947 (w), 1664 (s), 1516 (s), 1451 (m), 1325 (w), 1254 (m), 1193 (s), 
1182 (s), 1132 (s), 1032 (w), 837 (w), 801 (m), 759 (w), 741 (m), 721 (m), 699 (m); 1H NMR 
(400 MHz, DMSO-d6) δ 8.53 (s, 1H), 8.39 (d, J = 8.2 Hz, 1H), 8.22 (s, 1H), 7.87 (d, J = 7.9 
Hz, 1H), 7.83 (d, J = 7.5 Hz, 2H), 7.64 (d, J = 7.5 Hz, 2H), 7.50 (d, J = 7.9 Hz, 1H), 7.41–7.32 
(m, 3H), 7.30–7.22 (m, 3H), 7.20–7.13 (m, 7H), 7.13–7.06 (m, 8H), 4.27–4.18 (m, 2H), 4.17–
4.08 (m, 3H), 4.03–3.96 (m, 1H), 3.93–3.86 (m, 1H), 3.09–3.02 (m, 1H), 3.00–2.90 (m, 4H), 
2.90–2.81 (m, 2H), 2.72–2.63 (m, 1H), 1.65–1.49 (m, 2H), 1.46–1.11 (m, 6H). 13C NMR (126 
MHz, DMSO-d6) δ 174.66, 171.86, 170.74, 163.72, 157.41, 157.28, 156.45, 144.27, 144.21, 
144.18, 138.73, 138.38, 130.13, 129.38, 128.62, 128.29, 128.16, 127.55, 126.77, 126.46, 
125.77, 125.73, 120.62, 66.11, 56.09, 55.51, 54.43, 52.96, 47.09, 41.14, 40.83, 37.99, 37.53, 
30.50, 29.13, 25.19, 24.65; HR-MS (ESI): calcd for C45H54N10O7 - H+: 845.4220, found 
845.4105.
Characterisation data for Fmoc-dilysine -diphenylalanine (Fmoc-KKFF): IR: 3286 (m), 
3063 (m), 3034 (w), 2944 (m), 1663 (s), 1635 (s), 1524 (s), 1450 (m), 1412 (w), 1395 (m), 
1334 (w), 1254 (m), 1201 (s), 1182 (s), 1130 (s), 1082 (w), 1032 (w), 837 (w), 800 (w), 757 
(w), 739 (m), 722 (m), 697 (m); 1H NMR (400 MHz, DMSO-d6)  8.35 (d, J = 8.3 Hz, 1H), 
7.90-7.87 (m, 4H), 7.72-7.69 (m, 3H), 7.42 (t, J = 7.8 Hz, 3H), 7.33 (t, J = 7.4 Hz, 2H), 7.25-
7.15 (m, 10H), 4.37-4.13 (m, 6H), 3.96-3.91 (m, 1H), 3.09-2.89 (m, 4H), 2.76 – 2.64 (m, 5H), 
1.58-1.17 (m, 12H). 13C NMR (101 MHz, DMSO-d6) δ 172.99, 170.92, 155.95, 143.79, 140.73, 
138.25, 137.97, 129.53, 128.91, 128.07, 127.67, 127.07, 125.99, 125.28, 120.15, 65.54, 54.90, 
54.16, 46.67, 37.47, 37.33, 32.77, 31.31, 27.12, 26.58, 22.45, 22.30; HR-MS (ESI): calcd for 
C45H54N6O7 + H+: 791.4120, found 791.4196.
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Preparation of hydrogels
pH switch
For Fmoc-DDFF, Fmoc-EEFF, Fmoc-NNFF and Fmoc-QQFF, 3.5 equivalents of 0.1 M 
aqueous sodium hydroxide was added to the peptide and milliQ water added to make the 
suspension up to the required concentration. This suspension was sonicated until homogenous, 
upon which time 4.5 molar equivalents of glucono-δ-lactone was added to lower the pH, 
resulting in gelation.
Salt screening
Fmoc-RRFF and Fmoc-KKFF were dissolved in milliQ water at the appropriate concentration, 
before an equal volume of Dulbecco’s Modified Eagle Medium (DMEM) was added, to give 
the desired hydrogel concentration. 
AFM measurements
Gel samples were prepared according to the appropriate gelation trigger described above and 
one drop of the hydrogel solutions was cast onto a freshly cleaved mica substrate, followed by 
spreading of the drop over the mica using a glass slide, with the excess liquid wicked away 
using capillary action. Samples were cast at 2x below their minimum gel concentration and left 
to dry in air overnight. Imaging was undertaken on a Bruker Multimode 8 atomic force 
microscope in Scanasyst mode in air, whereby the imaging parameters are constantly optimised 
through the force curves that are collected, preventing damage of soft samples. Bruker 
Scanasyst-Air probes were used, with a spring constant of 0.4 - 0.8 N/m and a tip radius of 2 
nm.
Circular dichroism measurements
CD measurements for Fmoc-DDFF, Fmoc-EEFF, Fmoc-RRFF and Fmoc-KKFF were 
performed using a ChirascanPlus CD spectrometer, with data collected between wavelengths 
of 180 – 500 nm with a bandwidth of 1 nm, sample ratio of 0.1 s/point and step of 1 nm. CD 
measurements for Fmoc-NNFF and Fmoc-QQFF were collected on a Jasco J-1500 
spectrophotometer, with data collected between 180 – 500 nm with a bandwidth of 2 nm, digital 
integration time (D.I.T.) of 2 seconds, scan speed of 100 nm/min and data pitch of 0.1 nm. In 
a typical experiment, 1% (w/v) peptide sols or hydrogels were prepared as above and diluted 
as necessary in water. Temperature was kept constant at 25 °C and all experiments were 
repeated at least three times and averaged into a single plot.
Attenuated Total Reflectance-Infrared Spectroscopy measurements
For Fmoc-DDFF, Fmoc-EEFF, Fmoc-RRFF and Fmoc-KKFF, fourier transform infrared 
spectroscopy (FTIR) measurements were made on a Perkin Elmer Spotlight 400 FT-IR 
spectrophotometer equipped with a diamond crystal attenuated total reflectance (ATR) 
accessory. For Fmoc-NNFF and Fmoc-QQFF, measurements were made on a JASCO FT/IR 
4700 spectrophotometer fitted with a PIKE MIRacleTM Single Reflection ATR accessory and 
Page 13 of 27 ChemComm
ZnSe crystal plate. Hydrogels were prepared at 1% (w/v) in D2O and pressed between the 
diamond crystal and substrate. All spectra were scanned at least 16 times over the range of 
4000 - 650 cm-1 and were acquired at a resolution of 4 cm-1.
Rheology measurements
Rheological measurements were performed on an Anton Paar MCR 302 rheometer using a 25 
mm stainless steel parallel plate geometry configuration and analysed using RheoPlus v3.61 
software. Typical rheology measurements involved casting 550 µL of a peptide hydrogel at the 
desired concentration, using the appropriate trigger described above, onto one of the stainless 
steel plates, lowering the other plate to the measurement position, and monitoring the storage 
and loss moduli over time. Once the storage modulus had plateaued, frequency sweep 
measurements were commenced. A Peltier temperature control hood and solvent trap was used 
to reduce evaporation and maintain a temperature of 25 °C for frequency and amplitude sweeps. 
Frequency sweeps were performed with a log ramp frequency (f) = 0.01 – 10 Hz and constant 
strain ( = 0.2%. Strain sweeps were performed with a log ramp strain ( = 0.1 – 100% at a 
constant frequency (f) = 1 Hz. Time resolved rheology was performed at constant frequency 
(f) = 1 Hz and strain ( = 0.2%. The rheology plots displayed are an average of at least three 
repeats for each point and error bars denote two standard deviations from the log-averaged 
mean.
pKa measurements
Anionic and neutral polar tetrapeptides Fmoc-DDFF, Fmoc-EEFF, Fmoc-NNFF and Fmoc-
QQFF were dissolved at a concentration of 0.1% (w/v) through the addition of MilliQ water 
and 3.5 equivalents of 0.1 M NaOH. 0.1 M HCl was added in 50 µL aliquots, and the pH 
allowed to stabilise for several minutes before a reading was taken. For cationic tetrapeptides 
Fmoc-RRFF and Fmoc-KKFF, 3.5 equivalents of 0.1 M HCl and MilliQ water were added to 
dissolve the peptide at 0.1% (w/v) and 0.1 M NaOH added in 50 µL aliquots. Each titration 
was repeated three times and averaged into a single plot. pKa for Fmoc-DDFF and Fmoc-EEFF 
was determined to be the “buffering plateau” seen in Fig. S11, and pKb was calculated by 
determining the volume at which the equivalence point occurs through plotting the derivative 
of the graph, finding the pH at half of this volume and subtracting from 14.  
Zeta potential measurements
The zeta potential of peptide samples were measured using a Malvern Instruments Zetasizer 
NanoZS, equipped with a He-Ne laser beam with a wavelength of 633 nm and scattering angle 
of 12°. Measurements were performed in folded capillary cells (Malvern Instruments, 
DTS1070) using peptide sols prepared at 0.5% (w/v) (i.e. Fmoc-DDFF, Fmoc-EEFF, Fmoc-
QQFF, Fmoc-NNFF dissolved in basic water and Fmoc-RRFF, Fmoc-KKFF dissolved in 
acidic water) and hydrogels prepared at 1% (w/v) (using a GdL trigger for Fmoc-DDFF, Fmoc-
EEFF, Fmoc-NNFF and Fmoc-QQFF, and NaOH for Fmoc-RRFF and Fmoc-KKFF to avoid 
interference from buffer ions) which had then been dispersed in an equal volume of MilliQ 
water. 
Page 14 of 27ChemComm
Dye incubation measurements
Hydrogels were prepared using the appropriate method as described above. For the anionic 
Fmoc-DDFF, the peptide was dissolved in aqueous sodium hydroxide (0.1 M) and MilliQ water 
at a concentration of 1% (w/v) before the addition of glucono-δ-lactone. Before gelation 
occurred, an equal volume of 100 µM dye solution was added, giving a final concentration of 
50 µM dye and 0.5% (w/v) hydrogel. For the cationic Fmoc-KKFF, the peptide was dissolved 
in a 100 µM solution of dye, before an equal volume of 1x PBS (pH 7.4), giving final 
concentrations of 50 µM dye and 0.5% w/v) hydrogel. The gels were left to set overnight.
The next day, 1 mL 1x PBS (pH 7.4) was added to the gels and 500 µL aliquots removed at 1, 
2, 4, 6, 8, 12 and 24 hours. After each aliquot was removed, an equal volume of 1x PBS was 
added to the gel. Absorbance measurements were recorded on a Varian Cary 50 Bio UV-
Visible spectrophotometer. 
Cell viability measurements
Cytotoxicity measurements were performed using an Alamar Blue colorimetric assay on HEK-
293T cells. Each experiment was repeated at least three times. Cells were passaged using 
standard cell culture procedures. Cells were detached with trypsin and centrifuged (1000 rpm 
for 3 min). The supernatant was removed and the cells resuspended in Dulbecco’s Modified 
Eagle Medium (DMEM) at a concentration of 100,000 cells/mL. Cells were seeded at a 
concentration of 10,000 cells/well. 
For solution cytotoxicity measurements, cells were seeded into a 96 well plate and incubated 
overnight to attach to the substrate. Peptides were dissolved in DMSO and then diluted in 
DMEM to their desired concentration, with a final DMSO concentration of 1% (v/v). Media 
was then aspirated from the cells and replaced with 100 µL of the dissolved peptide solution in 
triplicate. Cells were then incubated for 24 hours and 10 µL Alamar Blue added to the wells, 
followed by incubation for 4 hours. Control wells included no cells, no treatment and a negative 
control of 20% (v/v) DMSO. The absorbance at 570 nm and 596 nm was recorded using a 
BioRad Benchmark plate reader.
For contact cytotoxicity measurements, to a 96-well plate, 100 L of gel was added in triplicate 
with their respective triggers and allowed to set overnight. Surrounding wells were 
supplemented with water to ensure hydration of the gels. Gels triggered with GdL were then 
incubated for 24 hours with PBS in order to buffer the gels and minimise the effects of any 
excess GdL. Cells were then seeded atop the hydrogels and incubated for 24 hours, before 10 
µL Alamar Blue was added to the wells, followed by further incubation for 4 hours. Control 
wells included cell-free gels, no hydrogels and a negative control of 20% (v/v) DMSO. The 
absorbance at 570 nm and 596 nm was recorded using a BioRad Benchmark plate reader.
Tethered bilayer lipid membrane experiments
Formation of tethered bilayer lipid membranes (tBLMs) was achieved using pre-prepared 
tethered benzyl-disulfide (tetra-ethyleneglycol) n = 2 C20-phytanyl tethers (DLP) and benzyl-
disulfide-tetra-ethyleneglycol-OH spacers (TEGOH) in the ratio of 1:9, as described previously 
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(SDx Tethered Membranes Pty. Ltd., Australia).1 To the tethering chemistry first layer was 
added 8 μL of a 3 mM solution of a mobile lipid-phase mixture of 1-palmitoyl-2-
oleoylphosphatidylcholine (POPC) lipids (Sigma-Aldrich) dissolved in ethanol. After a 2 min 
incubation, a rapid solvent exchange was undertaken with a buffer consisting of 100 mM NaCl 
and 10 mM tris at pH 7.2 to form the self-assembled tBLM. Swept frequency AC electrical 
impedance spectroscopy using a TethaQuick electrical impedance spectrometer (SDx Tethered 
Membranes Pty. Ltd., Australia) was used to determine membrane conduction. For this, phase 
and impedance magnitude data was collected using a 50 mV peak-peak AC excitation (2000 
Hz – 0.1 Hz). An equivalent circuit consisting of a Constant Phase Element (CPE) in series 
with a Resistor/Capacitor (RC) element representing the lipid membrane, and an extra resistor 
in series representing the NaCl/tris buffer, was used to fit the data. The CPE in this circuit 
represents the imperfect capacitance created by the chemically coated gold tethering electrode.2 
Data were fitted using a proprietary adaptation of a Levenberg–Marquardt fitting routine.  
Peptides were initially dissolved in water (for polar cationic tetrapeptides) or basic water (for 
polar anionic/neutral tetrapeptides) at a concentration of 1% (w/v) (approximately 10 mM) and 
diluted to the appropriate concentration using the NaCl/tris buffer described above. 
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Fig. S1 – Analytical HPLC traces of polar tetrapeptides. Chromatrograms were performed at 
room temperature using a 5-95% acetonitrile gradient and a Waters XBridge BEH130 C18 5 
µm 4.6 × 150 mm column.
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Fig. S2 – Minimum gel concentration tests for (a) Fmoc-DDFF, (b) Fmoc-EEFF, (c) Fmoc-
NNFF, (d) Fmoc-QQFF, which were performed using the pH switch method described above. 
Minimum gel concentration tests for (e) Fmoc-RRFF and (f) Fmoc-KKFF were carried out via 
the aforementioned salt screening method.
Table S1. Fibre diameters measured for each polar tetrapeptide. A minimum of 20 nanofibres 
were measured across multiple AFM images.
Peptide Fibre diameter (nm)
Fmoc-DDFF 5.5 ± 2.2
Fmoc-EEFF 6.5 ± 1.1
Fmoc-NNFF 2.8 ± 1.1
Fmoc-QQFF 6.4 ± 1.5
Fmoc-RRFF 6.1 ± 1.8
Fmoc-KKFF 4 ± 1.3
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Fig. S3 – (a) overlaid and (b-g) individual CD spectra of polar tetrapeptide hydrogels formed 
using either pH switch method (Fmoc-DDFF, Fmoc-EEFF, Fmoc-NNFF, Fmoc-QQFF) or salt 
screen method (Fmoc-RRFF, Fmoc-KKFF) at 1% (w/v) and dispersed in MilliQ water to 
achieved a final concentration of 0.125% (w/v).
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Fig. S4 – (a) Amide I region in the ATR-IR spectra of polar tetrapeptide hydrogels, full ATR-
IR spectra of tetrapeptide hydrogels of (b) Fmoc-DDFF, (c) Fmoc-EEFF, (d) Fmoc-NNFF, (e) 
Fmoc-QQFF, (f) Fmoc-RRFF and (g) Fmoc-KKFF. Hydrogels were prepared at 1% (w/v) 
using the appropriate methodology in D2O to avoid water O-H stretching vibrations at 1640 
cm-1 which interfere with the Amide I region of the peptides.
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Fig. S5 – Rheological characterisation of Fmoc-DDFF at (top) 0.25% (w/v), (middle) 0.5% 
(w/v) and (bottom) 1% (w/v), reflecting the concentrations used in contact cytotoxicity 
measurements. Measurements consist of (left column) time resolved rheology (f = 1 Hz and γ 
= 0.2%), (middle column) frequency sweep (f = 0.1-10 Hz and γ = 0.2%) and (right column) 
strain sweep (f = 1 Hz and γ = 0.1-100%). All measurements were performed at 25 °C.
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Fig. S6 – Rheological characterisation of Fmoc-EEFF at (top) 0.25% (w/v), (middle) 0.5% 
(w/v) and (bottom) 1% (w/v), reflecting the concentrations used in contact cytotoxicity 
measurements. Measurements consist of (left column) time resolved rheology (f = 1 Hz and γ 
= 0.2%), (middle column) frequency sweep (f = 0.1-10 Hz and γ = 0.2%) and (right column) 
strain sweep (f = 1 Hz and γ = 0.1-100%). All measurements were performed at 25 °C.
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Fig. S7 – Rheological characterisation of Fmoc-NNFF at (top) 0.25% (w/v), (middle) 0.5% 
(w/v) and (bottom) 1% (w/v), reflecting the concentrations used in contact cytotoxicity 
measurements. Measurements consist of (left column) time resolved rheology (f = 1 Hz and γ 
= 0.2%), (middle column) frequency sweep (f = 0.1-10 Hz and γ = 0.2%) and (right column) 
strain sweep (f = 1 Hz and γ = 1-100%). All measurements were performed at 25 °C.
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Fig. S8 – Rheological characterisation of Fmoc-QQFF at (top) 0.25% (w/v), (middle) 0.5% 
(w/v) and (bottom) 1% (w/v), reflecting the concentrations used in contact cytotoxicity 
measurements. Measurements consist of (left column) time resolved rheology (f = 1 Hz and γ 
= 0.2%), (middle column) frequency sweep (f = 0.1-10 Hz and γ = 0.2%) and (right column) 
strain sweep (f = 1 Hz and γ = 0.1-100%). All measurements were performed at 25 °C.
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Fig. S9 – Rheological characterisation of Fmoc-RRFF at (top) 0.5% (w/v) and (bottom) 1% 
(w/v), reflecting the concentrations used in contact cytotoxicity measurements. Measurements 
consist of (left column) time resolved rheology (f = 1 Hz and γ = 0.2%), (middle column) 
frequency sweep (f = 0.1-10 Hz and γ = 0.2%) and (right column) strain sweep (f = 1 Hz and γ 
= 0.1-100%). All measurements were performed at 25 °C.
Fig. S10 – Rheological characterisation of Fmoc-KKFF at (top) 0.5% (w/v) and (bottom) 1% 
(w/v), reflecting the concentrations used in contact cytotoxicity measurements. Measurements 
consist of (left column) time resolved rheology (f = 1 Hz and γ = 0.2%), (middle column) 
frequency sweep (f = 0.1-10 Hz and γ = 0.2%) and (right column) strain sweep (f = 1 Hz and γ 
= 0.1-100%). All measurements were performed at 25 °C.
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Fig. S11 – pKa and pKb determination for polar tetrapeptides. Polar anionic and neutral 
tetrapeptides were dissolved using 0.1 M NaOH and MilliQ water and 50 µL aliquots of 0.1 M 
HCl added. Polar cationic peptides were dissolved using 0.1 M HCl and MilliQ water and 50 
µL aliquots of 0.1 M NaOH added. Experiments were repeated at least three times. Equivalence 
points were determined through plotting the first derivative of the graph. 
Fig. S12 – UV-Visible spectrum of (a) Rhodamine 6G and (b) associated calibration curve with 
calculated extinction coefficient.
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Fig. S12 – Release of positively charged Rhodamine 6G fluorophore (inset) from hydrogels of 
(a) negatively charged Fmoc-DDFF and (b) positively charged Fmoc-KKFF. Hydrogels were 
prepared at 1% (w/v) and total release after 24 h was approximately 17% for Fmoc-DDFF and 
31% for Fmoc-KKFF, suggesting that peptide charge is conserved in the gel state. 
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